46
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Construction and Characterization of a Single-chain Antibody Fragment Derived from Thymus of a Patient with Myasthenia Gravis

, , , &
Pages 125-133 | Published online: 07 Jul 2009

  • Lindstrom, J., Shelton, D. and Fujii, Y. (1988) "Myasthenia gravis", Adv. Immunol. 42, 233 - 284
  • Graus, Y. and de Baets, M. (1993) "Myasthenia gravis: an autoimmune response against the acetylcholine receptor", Immunol. Res. 12, 78 - 100
  • Drachman, B. (1994) "Myasthenia gravis", N. Engl. J. Med. 330, 1797 - 1810
  • Lindstrom, J., Lennon, V., Seybold, M. and Whittingham, S. (1976) "Experimental autoimmune myasthenia gravis and myasthenia gravis: Biochemical and immunochemical aspects", Ann. N.Y. Acad. Sci. 274, 254 - 274
  • Toyka, K.V., Drachman, D.B., Pestronk, A. and Kao, I. (1975) "Myasthenia gravis: passive transfer from man to mouse", Science 190, 397 - 399
  • Tzartos, S.J., Hochschwender, S., Vasquez, P. and Lindstrom, J. (1987) "Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor", J. Neuroimmunol. 15, 185 - 194
  • Conti-Tronconi, B., Mclane, K., Raftery, M., Grando, S. and Protti, M. (1994) "The nicotinic acetylcholine receptor: structure and autoimmune pathology", Crit. Rev. Biochem. Mol. Biol. 29, 69 - 123
  • Lindstrom, J., Merlie, J. and Yogeeswaran, G. (1979) "Biochemical properties of acetylcholine receptor subunits from Torpedo californica", Biochemistry 18, 4465 - 4470
  • Raftery, M.A., Hunskappiler, M.W., Stradler, C.D. and Hood, L.E. (1980) "Acetylcholine receptor: complex of homologous subunits", Science 208, 1454 - 1457
  • Kubalek, E., Ralston, S., Lindstrom, J. and Unwin, N. (1987) "Localization of subunits within the acetylcholine receptor by electron image analysis of tubular crystals from Torpedo marmorata", J. Cell Biol. 105, 9 - 18
  • Barkas, T., Mauron, A., Roth, B., Alliod, C., Tzartos, S. and Ballivet, M. (1987) "Mapping of the main immunogenic region and toxin binding site of the nicotinic acetylcholine receptor", Science 235, 77 - 80
  • Barkas, T., Gabriel, J.-M., Mauron, A., Hughes, G., Roth, B., Alliod, C., et al., (1988) "Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor binds to residues 61-76 of the α-subunit", J. Biol. Chem. 263, 5916 - 5920
  • Tzartos, S.J., Kokla, A., Walgrave, S. and Conti-Tronconi, B. (1988) "Localization of the main immunogenic region of the human muscle acetylcholine receptor to residues 67-76 of the α-subunit", Proc. Natl Acad. Sci. USA 85, 2899 - 2903
  • Tzartos, S.J. and Lindstrom, J.M. (1980) "Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits", Proc. Natl Acad. Sci. USA 77, 755 - 759
  • Tzartos, S.J., Seybold, M.E. and Lindstrom, J.M. (1982) "Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies", Proc. Natl Acad. Sci. USA 79, 188 - 192
  • Tzartos, S., Barkas, T., Cung, M., Mamalaki, A., Marraud, M., Papanastasiou, D., et al., (1998) "Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor", Immunol. Rev. 163, 89 - 120
  • Lennon, V. and Lambert, E. (1980) "Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptor", Nature 285, 238 - 240
  • Graus, Y., Meng, F., Vincent, A., van Breda Vriesman, P. and de Baets, M. (1995) "Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis", J. Immunol. 154, 6382 - 6396
  • Tzartos, S.J. and Starzinski-Powitz, A. (1986) "Decrease in acetylcholine-receptor content of human myotube cultures mediated by monoclonal antibodies to α,β and γ subunits", FEBS Lett. 196, 91 - 95
  • Souroujon, M., Pachner, A. and Fuchs, S. (1986) "The treatment of passively transferred experimental myasthenia with anti-idiotypic antibodies", Neurology 36, 622 - 625
  • Wang, Z.-Y., Qiao, J. and Link, H. (1993) "Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor", J. Neuroimmunol. 44, 209 - 214
  • Wang, Z.-Y., Qiao, J., Melms, A. and Link, H. (1993) "T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis", Cell Immunol. 152, 394 - 404
  • Wang, Z.-Y., Huang, J., Olsson, T., He, B. and Link, H. (1995) "B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis", J. Neurol. Sci. 128, 167 - 174
  • Karachunski, P., Ostlie, N., Okita, D. and Conti-Fine, B. (1997) "Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences", J. Clin. Invest. 100, 3027 - 3035
  • Barchan, D., Sourojon, M., Im, S.-H., Antozzi, C. and Fuchs, S. (1999) "Antigen specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor a subunit", Proc. Natl Acad. Sci. USA 96, 8086 - 8091
  • Shi, F.D., Li, H., Wang, H., Bai, X., Van de Meide, P., Link, H., et al., (1999) "Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells", J. Immunol. 162, 5757 - 5763
  • Graus, Y., de Baets, M., Parren, P., Berrih-Aknin, S., Wokke, J., van Breda Vriesman, P., et al., (1997) "Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies", J. Immunol. 158, 1919 - 1929
  • Farrar, J., Portolano, S., Willcox, N., Vincent, A., Jacobson, L., Newsom-Davis, J., et al., (1997) "Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatoral library", Int. Immunol. 9, 1311 - 1318
  • Sophianos, D. and Tzartos, S. (1989) "Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against degradation caused by myasthenic sera", J. Autoimmun. 2, 779 - 789
  • Papanastasiou, D., Poulas, K., Kokla, A. and Tzartos, S.J. (2000) "Prevention of passively transferred experimental autoimmune myasthenia gravis by Fab fragments of monoclonal antibodies directed against the main immunogenic region of the acetylcholine receptor", J. Neuroimmunol. 104, 124 - 132
  • Papanastasiou, D., Mamalaki, A., Eliopoulos, E., Poulas, K., Liolitsas, C. and Tzartos, S. (1999) "Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor", J. Neuroimmunol. 94, 182 - 185
  • Mamalaki, A., Trakas, N. and Tzartos, S.J. (1993) "Bacterial expression of single-chain Fv fragment which efficiently protects the acetylcholine receptor against antigenic modulation caused by myasthenic antibodies", Eur. J. Immunol. 23, 1839 - 1845
  • Tsantili, P., Tzartos, S.J. and Mamalaki, A. (1999) "High affinity single-chain antibody fragments protecting the human nicotinic acetylcholine receptor", J. Neuroimmunol. 94, 15 - 27
  • De Wildt, R., Finnern, R., Ouwehand, W., Griffiths, A., van Venrooij, W. and Hoet, R. (1996) "Characterization of human variable domain antibody fragments against the U1 RNA-associated A protein, selected from a synthetic and a patient-derived combinatoral V gene library", Eur. J. Immunol. 26, 629 - 639
  • Hoet, R., Koornneef, I., de Rooij, D., van de Putte, L. and van Venrooij, W. (1992) "Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome", Arthritis Rheum. 35, 1202 - 1210
  • Luther, M., Schoepfer, R., Whiting, P., Casey, B., Blatt, Y., Montal, M., et al., (1989) "A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671", J. Neurosci. 9, 1082 - 1096
  • Kordossi, A.A. and Tzartos, S.J. (1989) "Monoclonal antibodies against the main immunogenic region of the acetylcholine receptor: mapping on the intact molecule", J. Neuroimmunol. 23, 35 - 40
  • Tzartos, S. and Remoundos, M. (1992) "Precise epitope mapping of monoclonal antibodies to the cytoplasmic site of the acetylcholine α-subunit. Dissecting a potentially myasthenogenic epitope", Eur. J. Biochem. 207, 915 - 922
  • Kabat, E., Wu, T., Perry, H., Gottesman, K. and Foeller, C. (1991) Sequences of proteins of immunological interest, 5th Ed. (National Institute of Health, Bethesda, MD), No 91-3242
  • Goel, A., Colcher, D., Koo, J.S., Booth, B., Pavlinkova, G. and Batra, S. (2000) "Relative position of the hexahistidine tag effects binding properties of a tumor-associated single-chain Fv construct", Biochim. Biophys. Acta 1519, 13 - 20
  • Xu, B., Kriangkum, J., Nagata, L.P., Fulton, R.E. and Suresh, M.R. (1999) "A single chain Fv specific against Western equine encephalitis virus", Hybridoma 18, 315 - 323
  • Alcocer, M.J., Doyen, C., Lee, H.A. and Morgan, M.R. (2000) "Properties of polyclonal, monoclonal, and recombinant antibodies recognizing the organophosphorus pesticide chlorpyrifos-ethyl", J. Agric. Food Chem. 48, 4053 - 4059
  • Hasshimoto, Y., Ikenaga, T., Tanigawa, K., Ueda, T., Ezakl, I. and Imoto, T. (2000) "Expression and characterization of human rheumatoid factor single-chain Fv", Biol. Pharm. Bull. 23, 941 - 945
  • Kuderova, A., Tanha, J. and Lee, J.S. (1994) "Characterization of four nucleic acid-binding single-chain Fv fragments by direct and competitive solid-phase radioimmunoassays", J. Biol. Chem. 269, 32957 - 32962
  • Casay, J.L., Keep, P.A., Chester, K.A., Robson, L., Hawkins, R.E. and Begent, R.H. (1995) "Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography", J. Immunol. Methods 13, 105 - 116
  • Long, M.C., Jager, S., Mah, D.C., Jebailey, L., Mah, M.A., Masri, S.A., et al., (2000) "Construction and characterization of a novel recombinant single-chain variable fragment antibody against Western equine encephalitis virus", Hybridoma 19, 1 - 13
  • Brown, J.C., Brown, 2nd, B.A., Li, Y. and Hardin, C.C. (1998) "Construction and characterization of a quadruplex DNA selective single-chain autoantibody from a viable motheaten mouse hybridoma with homology to telomeric DNA binding proteins", Biochemistry 37, 16338 - 16348
  • Berdichevsky, Y., Ben-Zeev, E., Lamed, R. and Benhar, I. (1999) "Phage display of a cellulose binding domain from clostridium thermocellum and its application as a tool for antibody engineering", J. Immunol. Methods 228, 151 - 162
  • Yuan, Q., Clarke, J., Zhou, H.-R., Linz, J., Pestka, J. and Hart, L. (1997) "Molecular cloning, expression, and characterization of a functional single-chain Fv antibody to the mycotoxin zearalenone", Appl. Environ. Microbiol. 63, 263 - 269
  • Li, J., Wang, Y., Wang, Z. and Dong, Z. (2000) "Influences of amino acid sequences in FR1 region on binding activity of the scFv and Fab of an antibody to human gastric cancer cells", Immunol. Lett. 71, 157 - 165
  • Benhar, I. and Pastan, I. (1995) "Identification of residues that stabilize the single-chain Fv of monoclonal antibodies B3", J. Biol. Chem. 270, 23373 - 23380
  • Ohtomo, T., Tsuchiya, M., Sato, K., Simizu, K., Moriuchi, S., Miyao, Y., et al., (1995) "Humanization of mouse ONS-M21 antibody with the aid of hybrid variable regions", Mol. Immunol. 32, 407 - 416
  • Li, Y., Spellerberg, M.B., Stevenson, F.K., Capra, J.D. and Potter, K.N. (1996) "The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3", J. Mol. Biol. 256, 577 - 589
  • De Haard, H.J., Kazemier, B. and van der Bent, A. (1998) "Absolute conservation of residue 6 of immunoglobulion heavy chain variable regions of class IIA is required for correct folding", Protein Engng 11, 1267 - 1276
  • Padlan, E.A. (1991) "A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties", Mol. Immunol. 28, 489 - 498

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.